Áèîëîãè÷åñêèå
íàóêè/ 9. Áèîõèìèÿ
è
áèîôèçèêà
MD Rasulov M.M., DCh Storozhenko
P.A., student Susova M.I.,
BioD Snisarenko T.A.,
post-graduate Rasulov R.M.,
State Research Institute for Chemistry and Technology of Organoelement
Compounds, Moscow
AMINOACYL
TRNA SYNTHETASES PARTICIPATION
IN PHYSIOLOGICAL PROCESSES CONTROL
Aminoacyl tRNA synthetases (aaRS)
are enzymes of nonribosomal stage of
protein synthesis. They perform one of the central functions in the cell
ensuring genetic code embodiment accuracy by means of specific amino acid
addition to homological tRNA. It means that even on the early stages of
cellular forms of life aaRSes were one of the first enzymes that “filled in”
the necessary link in the process of genetic information embodiment. As an example: tyrosyl- tRNA - synthetas -
TyrRS, tryptophanyl - tRNA - synthetas – TrpRS, Seryl-tRNA
synthetase (SerRS). Demand for
precise control over metabolic reactions simultaneously occurring in a cell
promoted multienzyme complexes development.
In its turn, aminoacylation efficiency resulted from targeted transport
of amino acids and regulator factors pool set up.
The pathologies which are associated
with aaRSes include: Charcot-Marie-Tooth neuropathy; erroneous acylation and
tentorium dysfunction; leukoencephalopathy which includes brainstem lesion and
spinal injury, higher lactate (LBSL) level, Parkinson's disease, oncological
diseases (disorder in synthesis of a specific set of proteins and enzymes of a
protein-synthesizing apparatus, abnormal activation of Methionyl-tRNA synthetase, conjugation with
other proteins of cysteinyl-tRNA synthetase, mutations in the promoter region
and overexpression of isoleucyl-tRNA synthetase, overexpression of alpha -
subunit of phenylalanyl-tRNA synthetase, overexpression of glycyl - and lysyl-
tRNA synthetase at various cancer
kinds) and finally, autoimmune diseases and
diabetes. Considered series of studies led us to the initial problems of
catalytic center structure, as such, as well as support structures of protein
macromolecules defined as “pockets” and structural determinants for ligand
binding – amino acids, ATP and tRNA. Furthermore, a great variety of proteins and
enzymes in the process of evolution was provided by mean of so called
“alternative splicing” representing all-pervading principle of molecular
protein diversity without sharp increase of genetic material (for example,
TrpRS) for eukaryotes and other higher organisms. We have determined TrpRS
responsibility in cellular metabolism of higher organisms. TrpRS secretion,
alternative splicing, TrpRS mRNA synthesis promotion under the effect of
gamma-interferon were found, as well as
the presence of non-angiogenic (which means antioncogene and
antiatherogenic) activity TrpRS clipped form. We believe that these kinds of
activity depend on zinc cation as part of TrpRS and its participation along
with other enzyme systems in synthesis of dinucleotide polyphosphates (ApnA), Àð3À in particular. We were the first to discover zinc ions in TrpRS. It is
common knowledge that zinc is an enzyme activator, but stoichiometric
relationship and lability of zinc bond with the enzyme remained unclear. This
situation gave us a reason to carry out experiments with zinc removal from the
enzyme. The enzyme activity was found to reduce which confirms the hypothesis.
We also found additional TrpRS
activity, in particular its ability to Àð3À synthesis. Data concerning the importance of Ap3A and Ap4A relationship
in a cell are of special interest. Ap3A excess on Ap4A leads to cell
proliferation and differentiation but when the ratio is reverse a cell is
subject to an adjustable death in the process of apoptosis. Moreover aaRS is
evidently synthesized as an apoenzyme, and its activity is determined by zinc
availability in the cell.
Possibility of some metals
hypervalent compounds synthesis underlay the development of bioactive silicon
compounds. This discovery of M.G. Voronkov allowed to create a new branch of
silicon chemistry – bioorganosilicon chemistry. It was found that silatranes
promote enzymes and nucleic acids synthesis, intensify proliferative and reparative
function of connective tissue, accelerate the healing of wounds and burns, have
anti-stress and adaptogenic effect [1, 2].
In recent years hypervalent zinc
compounds - zincatranes - RZn(CH2CH2)n have been synthesized, their biological activity is
being studied [3]. Zincatrane was found to have antidotal action at ethanol
intoxication, at the same time it promotes triptophanyl synthetase activity
[4]. This allows us to declare a new trend in pharmacology - "Molecular
Pharmacology of organometallic compounds".
References
1. Rasulov M.M., Voronkov M.G.
Organoelement compounds for medications: yesterday, today and tomorrow //
Vestnik RAEN, 2008, v.8., No 1, p.82-86.
2. Rasulov M.M., Nurbekov M.K.,
Susova M.I. Aminoacyl tRNA synthetases participation in physiological processes
monitoring in health and disease // In: Phytotherapy and Folk Medicine of
Avicenna Period. Dushanbe, 2010, p.314-316
3.
Voronkov M.G., Adamovich S.N., Mirskov R.G., Mirskova A.N. Synthesis of new bioactive Î-hydrometalloatranes
// Zhurnal Obshchei Khimii, 2009, v.79, ¹1, p.162-163.
4. Voronkov M. G., Nurbekov M. K. Rasulov M.M., Zvereva M. V.,
Mirskova A. N., R. G. Mirskov Adamovich S. N.
The Complex of Zinc bis-(2- Methylphenoxyacetate) with Tris -2 (hydroxyl-ethyl) Amine as an Activator of Synthesis of Total
Tryptophanyl -tRNA Synthetase. // Doklady Biochemistry and Biophysics, 2012,
Vol. 444, pp. 147–148.